Recurrent Osteosarcoma Completed Phase 1 / 2 Trials for RG-4733 (DB11870)

Also known as: Osteosarcoma recurrent / Osteogenic sarcoma recurrent

IndicationStatusPhase
DBCOND0028757 (Recurrent Osteosarcoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01154452Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaTreatment